Support Dosing Program Lead across assets and may serve as dosing program representative on clinical trial teams
Contribute to the writing and editing of clinical study protocols, clinical study reports, manuscripts, and other study-related documents
Contribute to ongoing data review and cleaning, data summarization and analysis in support of abstracts, manuscripts and presentations for external meetings and conferences
Definium Therapeutics, formerly known as Mind Medicine, is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Founded in 2019, they are continuously expanding their presence and global footprint with a team of patient-centric, intelligent individuals.
Bring medical and scientific expertise to the design, execution, and interpretation of clinical studies ensuring patient safety and scientific integrity
Author and oversee key clinical documents including protocols, amendments, informed consent forms, investigator brochures, clinical study reports, and regulatory submissions
Review, analyze, and interpret emerging clinical data (safety, efficacy, PK/PD) to identify trends and issues, ensuring timely resolution through cross-functional collaboration
Definium Therapeutics, formerly known as Mind Medicine, is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Founded in 2019, they are continuously expanding our presence and global footprint, searching for high-impact individuals in various clinical, technical and business operations domains to strengthen our team.
Leads the cross-functional Trial Team (CTT); tracking of project deliverables & timelines.
Identifies risks and ensures mitigation and contingencies are being initiated and followed through (including management of CAPAs)
Accountable for the delivery of the trial within agreed/projected life of trial budget.
Definium Therapeutics, formerly known as Mind Medicine, is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Founded in 2019, they are continuously expanding their presence and global footprint and searching for high-impact individuals.